Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation.
Gibellini D, De Crignis E, Ponti C, Borderi M, Clò A, Miserocchi A, Viale P, Re MC. Gibellini D, et al. Among authors: borderi m. Biochem Biophys Res Commun. 2010 Oct 22;401(3):429-34. doi: 10.1016/j.bbrc.2010.09.071. Epub 2010 Sep 24. Biochem Biophys Res Commun. 2010. PMID: 20869948
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.
Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, Clò A, Gibellini D, Quiros-Roldan E, Brianese N, Cesana BM, Re MC, Torti C. Focà E, et al. Among authors: borderi m. BMC Infect Dis. 2012 Feb 14;12:38. doi: 10.1186/1471-2334-12-38. BMC Infect Dis. 2012. PMID: 22333484 Free PMC article. Clinical Trial.
Biases in bone metabolism studies.
Borderi M, Viale P. Borderi M, et al. Acta Biomed. 2012 Apr;83(1):69-71. Acta Biomed. 2012. PMID: 22978062
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.
Calza L, Trapani F, Salvadori C, Magistrelli E, Manfredi R, Colangeli V, Di Bari MA, Borderi M, Viale P. Calza L, et al. Among authors: borderi m. Scand J Infect Dis. 2013 Feb;45(2):147-54. doi: 10.3109/00365548.2012.712213. Epub 2012 Sep 19. Scand J Infect Dis. 2013. PMID: 22991923
156 results